Anixa Biosciences Inc (ANIX) AI Dilution Summary

Cash was $13,864,000 at 2026-07-31 against estimated monthly burn of $590,000. The company's funding channel is its active at-the-market program with Cantor Fitzgerald & Co., which is authorised to $100,000,000 and has $5,457,367.13 sold to date. Dilution here is driven primarily by that ATM program, which has $95,000,000 of remaining capacity stated in dollars.